⚠️ Jeunes docteurs : Lors du congrès la SFM_Microbiologie remettra trois prix de thèse à de jeunes docteurs en microbiologie âgés de moins de 35 ans et ayant soutenu leur thèse d’université entre juin 2021 et juin 2022.

🆕🔥 La section Virologie de la SFM est heureuse de vous annoncer son prochain #webinar sur les infections par le virus #Monkeypox le lundi 4 juillet entre 12h00 et 13h30. Inscription gratuite mais obligatoire app.livestorm.co/sfm-microbiolo…

Fast and robust discovery of antipoxvirus inhibitors using ANCHOR tagged viruses. A 25 field reconstruction is shown for each condition (blue: nuclei, green: VACV ANCHOR), showing that compound 1 completely abolish virus replication. [email protected]

Orthopox titration using high resolution imaging. A reconstruction of 374 fields, 3 picture /field (R/G/B) and displayed in real color. It took 5 min to acquire the 1122 images and reconstruct the full well. Is it useful in routine ? Of course not. Is it cool ? Indeed :)

Picture of the month, october 2022. SARS-CoV-2 infecting human pulmonary cells 48h post-infection, nuclei in blue, SARS-CoV-2 RNA in green, SARS-CoV-2 NP in red. Work done by Charlotte Quentin-Froignant.

Très heureux d’avoir pu sponsoriser une partie des prix poster du colloque #Biotechnocentre. Les prix ont été décernés à Clément Rivière pour ses travaux sur un traitement du glioblastome et à M. Valentin Beauvais pour ses travaux sur le contrôle qualité des mRNP. Félicitations !

📢OUT NOW: Tecovirimat blocks replication of 2022 MPXV isolate in vitro, supporting its use in ongoing human clinical trials NeoVirTech Etienne Simon-Loriere Jean-nicolas Tournier nature.com/articles/s4156…

Delighted to see our work on the efficiency of Tecovirimat on the European Monkeypox virus strain published today in nature Microbiology (IF=31) ! nature.com/articles/s4156…

Picture of the month, November 2022 hCMV ANCHOR strain infecting human primary fibroblast. Want to challenge your product on our autofluorescent virus collection ? Contact us at [email protected]

Our article on the cover!

We had the chance to present the progress of our DENALPOVIR project during the first edition of the Defense Health Innovation Day at the Val-De-Grâce School. This event was an opportunity to discover 37 innovative projects selected by the French Army Health Service (SSA) !

Picture (art) of the month, January 2023. Human cells infected with VACV ANCHOR poxvirus (green: infected cells, green dots: viral DNA) and stained with WGA 555 (Magenta) and DAPI (blue) 20h post infection. We wish you a colorful year ! 😊

We are sponsoring the International Conference on Antiviral Research to be held in Lyon March 13-17. . We will present our last project on the development of broad spectrum antivirals and have some time to visit and discuss with our partners #ICAR

Strategical alliance with VirexpR, leader in airborne disinfection testing in France. Collaboration will allow NeoVirTech to use VirexpR nebulization room to measure the efficiency of air treatment devices using an imaged based readout. [email protected] [email protected]

Reconstructed human airway epithelium infected with SARS-CoV-2 Omicron strain and stained for SARS-CoV-2 NP (red) and SARS-CoV-2 RNA (green). This work is a collaboration between NeoVirTech, expert in virus imaging, and @Virnext, expert in viral respiratory infectious diseases.

Elegant work and nice to put numbers on the forces! RNA pol2 is not even bothered by ParB proteins at parS sites - the ANCHOR system - in eucaryotes: doi.org/10.1016/j.bpj.… CBI Toulouse NeoVirTech

Picture of the month, June 23 (click for full res). African Swine Fever Virus tagged ANCHOR™ infecting Vero cells and fixed 16h post infection. This work is in collaboration with Dr Ali Alejo Herberg from the Centro de Investigacion en Sanidad Animal in Madrid, Spain.

I had the chance to visit the veterinary clinic of the ZooParc de Beauval today. We discussed several problematic on virus outbreak management and disinfection strategies. I’m truly convinced it will be a very productive collaboration between our institutes.

NeoVirTech’s team is growing. It is our pleasure to welcome Charlène Lopez as an engineer, in charge of the development of oncolytic viruses, from design, construct, validation to in vivo testing. Welcome Charlène !

Jan 2024: The pace speeds up! In the New Year, we'll be putting out more of our ANCHOR viruses to answer all your questions! Whether you're developing antivirals, physical or chemical disinfection systems, oncolytic viruses or need high-throughput imaging and analysis!